167 related articles for article (PubMed ID: 10740219)
1. Glyceraldehyde-3-phosphate dehydrogenase and apoptosis.
Berry MD; Boulton AA
J Neurosci Res; 2000 Apr; 60(2):150-4. PubMed ID: 10740219
[TBL] [Abstract][Full Text] [Related]
2. Role of Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) in DNA Repair.
Kosova AA; Khodyreva SN; Lavrik OI
Biochemistry (Mosc); 2017 Jun; 82(6):643-654. PubMed ID: 28601074
[TBL] [Abstract][Full Text] [Related]
3. Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration and apoptosis signaling.
Tatton WG; Chalmers-Redman RM; Elstner M; Leesch W; Jagodzinski FB; Stupak DP; Sugrue MM; Tatton NA
J Neural Transm Suppl; 2000; (60):77-100. PubMed ID: 11205159
[TBL] [Abstract][Full Text] [Related]
4. Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase in neurodegenerative processes and the role of low molecular weight compounds in counteracting its aggregation and nuclear translocation.
Gerszon J; Rodacka A
Ageing Res Rev; 2018 Dec; 48():21-31. PubMed ID: 30254002
[TBL] [Abstract][Full Text] [Related]
5. Proapoptotic protein glyceraldehyde-3-phosphate dehydrogenase: a possible site of action of antiapoptotic drugs.
Ishitani R; Tajima H; Takata H; Tsuchiya K; Kuwae T; Yamada M; Takahashi H; Tatton NA; Katsube N
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Apr; 27(2):291-301. PubMed ID: 12657368
[TBL] [Abstract][Full Text] [Related]
6. Glyceraldehyde-3-phosphate dehydrogenase as a target for small-molecule disease-modifying therapies in human neurodegenerative disorders.
Berry MD
J Psychiatry Neurosci; 2004 Sep; 29(5):337-45. PubMed ID: 15486605
[TBL] [Abstract][Full Text] [Related]
7. Glyceraldehyde-3-phosphate dehydrogenase: Aggregation mechanisms and impact on amyloid neurodegenerative diseases.
Muronetz VI; Barinova KV; Stroylova YY; Semenyuk PI; Schmalhausen EV
Int J Biol Macromol; 2017 Jul; 100():55-66. PubMed ID: 27215901
[TBL] [Abstract][Full Text] [Related]
8. [The biological significance of oxidative modifications of cysteine residues in proteins illustrated with the example of glyceraldehyde-3-phosphate dehydrogenase].
Rodacka A; Gerszon J; Puchała M
Postepy Hig Med Dosw (Online); 2014 Mar; 68():280-90. PubMed ID: 24662796
[TBL] [Abstract][Full Text] [Related]
9. Nuclear translocation of glyceraldehyde-3-phosphate dehydrogenase isoforms during neuronal apoptosis.
Saunders PA; Chen RW; Chuang DM
J Neurochem; 1999 Mar; 72(3):925-32. PubMed ID: 10037463
[TBL] [Abstract][Full Text] [Related]
10. Regulation of Autophagy by Nuclear GAPDH and Its Aggregates in Cancer and Neurodegenerative Disorders.
Butera G; Mullappilly N; Masetto F; Palmieri M; Scupoli MT; Pacchiana R; Donadelli M
Int J Mol Sci; 2019 Apr; 20(9):. PubMed ID: 31027346
[TBL] [Abstract][Full Text] [Related]
11. Protein thiol modification of glyceraldehyde-3-phosphate dehydrogenase as a target for nitric oxide signaling.
Brüne B; Lapetina EG
Genet Eng (N Y); 1995; 17():149-64. PubMed ID: 7540026
[TBL] [Abstract][Full Text] [Related]
12. Glyceraldehyde-3-phosphate dehydrogenase is required for efficient repair of cytotoxic DNA lesions in Escherichia coli.
Ferreira E; Giménez R; Cañas MA; Aguilera L; Aguilar J; Badia J; Baldomà L
Int J Biochem Cell Biol; 2015 Mar; 60():202-12. PubMed ID: 25603270
[TBL] [Abstract][Full Text] [Related]
13. New insights into an old protein: the functional diversity of mammalian glyceraldehyde-3-phosphate dehydrogenase.
Sirover MA
Biochim Biophys Acta; 1999 Jul; 1432(2):159-84. PubMed ID: 10407139
[TBL] [Abstract][Full Text] [Related]
14. Glyceraldehyde-3-phosphate, a glycolytic intermediate, prevents cells from apoptosis by lowering S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase.
Lee SY; Kim JH; Jung H; Chi SW; Chung SJ; Lee CK; Park BC; Bae KH; Park SG
J Microbiol Biotechnol; 2012 Apr; 22(4):571-3. PubMed ID: 22534308
[TBL] [Abstract][Full Text] [Related]
15. Role of the glycolytic protein, glyceraldehyde-3-phosphate dehydrogenase, in normal cell function and in cell pathology.
Sirover MA
J Cell Biochem; 1997 Aug; 66(2):133-40. PubMed ID: 9213215
[TBL] [Abstract][Full Text] [Related]
16. Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases.
Chuang DM; Hough C; Senatorov VV
Annu Rev Pharmacol Toxicol; 2005; 45():269-90. PubMed ID: 15822178
[TBL] [Abstract][Full Text] [Related]
17. Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) interacts with apurinic/apyrimidinic sites in DNA.
Kosova AA; Khodyreva SN; Lavrik OI
Mutat Res; 2015 Sep; 779():46-57. PubMed ID: 26203648
[TBL] [Abstract][Full Text] [Related]
18. Phenylephrine protects cardiomyocytes from starvation-induced apoptosis by increasing glyceraldehyde-3-phosphate dehydrogenase (GAPDH) activity.
Yao LL; Wang YG; Liu XJ; Zhou Y; Li N; Liu J; Zhu YC
J Cell Physiol; 2012 Oct; 227(10):3518-27. PubMed ID: 22252379
[TBL] [Abstract][Full Text] [Related]
19. [Properties and functional diversity of glyceraldehyde-3-phosphate dehydrogenase].
Rodacka A
Postepy Hig Med Dosw (Online); 2013 Aug; 67():775-89. PubMed ID: 24018444
[TBL] [Abstract][Full Text] [Related]
20. Glyceraldehyde-3-phosphate dehydrogenase aggregation inhibitor peptide: A potential therapeutic strategy against oxidative stress-induced cell death.
Itakura M; Nakajima H; Semi Y; Higashida S; Azuma YT; Takeuchi T
Biochem Biophys Res Commun; 2015 Nov; 467(2):373-6. PubMed ID: 26431872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]